- Published at
- by financialpost.com
positive
positive
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
LAVAL, Quebec — Crescita Therapeutics Inc. (
News for Crescita Therapeutics Inc. (CTX.TO)
- Published at
- by financialpost.com
neutralneutral- Published at
- by financialpost.com
positivepositiveLeading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
LAVAL, Quebec — Crescita Therapeutics Inc. (- Published at
- by financialpost.com
positivepositiveCrescita to Acquire Strategic Assets of Occy Laboratory
LAVAL, Quebec — Crescita Therapeutics Inc. (- Published at
- by marketscreener.com
positivepositiveCrescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
Crescita Therapeutics Inc. , a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its Annual General and Special Meeting of...- Published at
- by financialpost.com
mixedmixedCrescita Reports First Quarter 2024 Results
LAVAL, Quebec — Crescita Therapeutics Inc. (- Published at
- by financialpost.com
mixedmixedCrescita Reports Q4 and Fiscal 2023 Results
LAVAL, Quebec — Crescita Therapeutics Inc. (- Published at
- by marketscreener.com
neutralneutralCrescita Reports Q4 and Fiscal 2023 Results
Crescita Therapeutics Inc. , a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the fourth quarter and fiscal year ended December...- Published at
- by financialpost.com
positivepositiveCrescita Therapeutics Announces Approval of Normal Course Issuer Bid
LAVAL, Quebec — Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“- Published at
- by prnewswire.com
positivepositiveCroma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe
/PRNewswire/ -- Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch...- Published at
- by prnewswire.com
mixedmixedTopical Drugs Market Size to Grow by USD 70.95 billion from 2021 to 2026 | Driven by Increase in the Prevalence of Skin Diseases | Technavio
/PRNewswire/ -- The topical drugs market size is set to grow by USD 70.95 billion from 2021 to 2026, progressing at a CAGR of 7.73% according to the latest...